RYOAX Mutual Fund (Rydex Biotechnology Fund Class H) is managed by Rydex Funds with $4.8M in net assets. RYOAX expense ratio is 1.64%, holding 76 positions across sectors including Health Care, Unknown, Materials. Inception date: 1998-04-01.

RYOAX performance shows a YTD return of 3.94%. The 1-year return is 47.66% and the 5-year return is 9.81%. RYOAX dividend yield stands at 15.56%, paid annually.

RYOAX top holdings include Abbvie Inc (8.8%), Amgen Inc. (5.3%), Gilead Sciences Inc (4.9%), Nvaesrtex Pharmaceuticals Inc (4.3%), Alnylam Pharmace (3.3%). View all RYOAX holdings, sector breakdown, or dividend history.

RYOAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RYOAX alternatives are available via the screener, along with tax-loss harvesting opportunities.